Because of the lethality associated with AURKB defects, our focus was solely on investigating NSFL1C, and our findings revealed that its loss could promote the growth of prostate tumors with BRCA2 deficiency (Supplemental Figure 6B). Here, BRCA2 is linked to prostate neoplasm.